How depression may increase cardiac risk: Effect of hypercortisolism on platelet activation markers - Preliminary data

Neuropsychobiology

Volumn 57, Issue 3, 2008, Pages 146-150

  Baranyai, Réka ^a,b   Nonell, Annemarie ^a   Deuschle, Michael ^a   Lederbogen, Florian ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiovascular; Cortisol; Depression; Hydrocortisone; Hypercortisolism; P selectin; Platelet

Indexed keywords

CD45 ANTIGEN; GLYCOPROTEIN; GLYCOPROTEIN 53; HYDROCORTISONE; PADGEM PROTEIN; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CELL SURFACE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; HYPERCORTISOLISM; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; ANTIGENS, CD; BLOOD PLATELETS; CROSS-OVER STUDIES; CUSHING SYNDROME; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DUAL SPECIFICITY PHOSPHATASE 2; HUMANS; HYDROCORTISONE; MALE; P-SELECTIN; PILOT PROJECTS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; REFERENCE VALUES;

EID: 47949119328     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142362     Document Type: Article

References (29)

1. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580-592.
2. Kopp MS, Rethelyi J: Where psychology meets physiology: chronic stress and premature mortality - the Central-Eastern European health paradox. Brain Res Bull 2004;62:351-367.
3. Glassman AH, Shapiro PA: Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
4. Carney RM, Freedland KE, Jaffe AS: Depression as a risk factor for coronary heart disease mortality. Arch Gen Psychiatry 2001;58:229-230.
5. Serebruany VL, Glassman AH, Malinin AI, Sane DC, Finkel MS, Krishnan RR, Atar D, Lekht V, O'Connor CM: Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 2003;14:563-567.
6. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, Marzec U, Harker LA, Nemeroff CB: Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-1317.
7. Strike PC, Steptoe A: Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis 2004;46:337-347.
8. Heuser I: The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 1998;31:10-13.
9. Tafet GE, Toister-Achituv M, Shinitzky M: Enhancement of serotonin uptake by cortisol: a possible link between stress and depression. Cogn Affect Behav Neurosci 2001;1:96-104.
10. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L: Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002;415:175-179.
11. La Brocca A, Terzolo M, Pia A, Paccotti P, De Giuli P, Angeli A: Recurrent thromboembolism as a hallmark of Cushing's syndrome. J Endocrinol Invest 1997;20:211-214.
12. Mielke CH Jr, Levine PH, Zucker S: Preoperative prednisone therapy in platelet function disorders. Thromb Res 1981;21:655-662.
13. Hutter JJ, Hathaway WE: Prednisone-induced hemostasis in a platelet function abnormality. Am J Dis Child 1975;129:641-643.
14. Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M: Ligand-specific glucocorticoid receptor activation in human platelets. Blood 2005;106:4167-4175.
15. Schulze H, Shivdasani RA: Mechanisms of thrombopoiesis. J Thromb Haemost 2005;3:1717-1724.
16. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
17. George JN, Shattil SJ: The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991;324:27-39.
18. Nonell A, Bodenseh S, Lederbogen F, Kopf D, Hamann B, Gilles M, Deuschle M: Chronic but not acute hydrocortisone treatment shifts the response to an orthostatic challenge towards parasympathetic activity. Neuroendocrinology 2005;81:63-68.
19. Gurbel PA, Serebruany VL, Shustov AR, Dalesandro M, Gumbs CI, Grablutz LB, Bahr RD, Ohman EM, Topol EJ: Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis. Coron Artery Dis 1998;9:451-456.
20. Gurbel PA, O'Connor CM, Dalesandro MR, Serebruany VL: Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy. Am J Cardiol 2001;87:774-777. 21 Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, Emoto M, Tahara H, Inaba M, Hino M, Shioi A, Miki T, Nishizawa Y: Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003;108:524-529.
21. Abrams C, Shattil SJ: Immunological detection of activated platelets in clinical disorders. Thromb Haemost 1991;65:467-473.
22. Israels SJ, McMillan-Ward EM, Easton J, Robertson C, McNicol A: CD63 associates with the αIIb β3 integrin-CD9 complex on the surface of activated platelets. Thromb Haemost 2001;85:134-141.
23. Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Freund M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, Jackson SP: A revised model of platelet aggregation. J Clin Invest 2000;105:783-791.
24. Fullard JF: The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des 2004;10:1567-1576.
25. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH: Unstable angina pectoris. N Engl J Med 2000;342:101-114.
26. O'Brien JR: Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature 1963;200:763-764.
27. Weber C: Platelets and chemokines in atherosclerosis: partners in crime. Circ Res 2005;96:612-616.
28. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD Jr, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW: Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 2000;97:325-330.
29. George JN: Platelets. Lancet 2000;355:1531-1539.